BCL2 and esophageal squamous cell carcinoma: Further reported CASC9 target genes were CDK4, CyclinD1 (CCND1), E-Cadherin (CDH1) and BCL2 in lung adenocarcinoma [26], ESCC cells [12], oral squamous cell carcinoma [31] and in breast cancer [32].